Poster Presentation

Friday, July 13, 2007
9:30 AM - 10:15 AM

Friday, July 13, 2007
3:15 PM - 4:00 PM
This presentation is part of : Poster Presentation III
Development of Evidence-based Nursing Practice Guidelinefor Non-Phamacologic Management of Constipation in Institutionalized Elderly
Taenam Park, PhD, RN, Department of Nursing, Kyungdong College of Techno-Information, Department of Nursing, Gyeongsan, South Korea and Myungae Kim, PhD, RN, College of Nursing, Keimyung, Daegu, South Korea.
Learning Objective #1: The learner will be able to know how to manage nonphamacological intervention of constipation in institutionalized elderly
Learning Objective #2: The learner will be able to know effect of nsg practice guideline of constipation

  The purpose of this study was to develop evidence-based nursing practice guideline for non-phamacologic management of constipation in institutionalized elderly. Ultimately, the purpose of this guideline is to reduce severity of constipation and to prevent recurrence of constipation through adequate management of constipation without the use of laxatives.

  This study was performed by methodological design. Summarized below are 8 procedures according to developmental process of evidence based guideline in The Scottish Intercollegiate Guidelines Network(SIGN) to develop this guideline.

  The Result from this study were as follows:

  This guideline consists of 5 categorial recommendations, 17 recommendations and 43 sub recommendations in guideline: recommendation for assessment of constipation recommendation for palliative practice of constipation recommendation for preventive practice of recurrent constipation recommendation  for evaluation of constipation   recommendations for organizational team approach and recommendations for education of nurse, patient and the family.

  Additionally, the result from the analysis of cost-effectiveness through pilot-application of guideline in the actual clinical setting were as follows:

  There was a significant decrease in frequency of constipation(2=23.01, p=.000) and severity of constipation(t=6.13, p=.000), and quality of life was significantly improved (t=6.63, p=.000) after pilot-application of guideline. In the cost per week, medication and procedure cost was slightly decreased, but the time cost was increased 1.59 times compared with non application of guideline.

  Based on the results described above, this study can be used as a baseline data for the future study in developing the evidence based guideline.